Quarterly report [Sections 13 or 15(d)]

STOCKHOLDERS' EQUITY

v3.25.1
STOCKHOLDERS' EQUITY
 3 Months Ended
Mar. 31, 2025
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY
NOTE 10 — STOCKHOLDERS' EQUITY
As of December 31, 2024, the Company had 78,200 exercisable common warrants outstanding, with a contractual exercise price of $0.80 per warrant, expiring five years from initial issuance in October 2020. During the three months ended March 31, 2025 and 2024, no common warrants were exercised. The following table reflects the common warrants
exercised, including the proceeds received for such exercises. As of March 31, 2025, there remained 78,200 exercisable common warrants.
Common Warrants Exercise Price Proceeds Received
Exercisable, December 31, 2023 78,200 $ 0.80 
Exercised — —  $ — 
Exercisable, March 31, 2024 78,200 $ 0.80 
Exercisable, December 31, 2024 78,200 $ 0.80 
Exercised — —  $ — 
Exercisable, March 31, 2025 78,200 $ 0.80